LONDON: Scientists at Porton Down, the Defence Science and Technology Laboratory in the UK, have achieved a significant breakthrough in the treatment of Q fever, a disease caused by the bacteria Coxiella burnetii.
Utilizing advanced robot technology, the researchers meticulously screened over 2,000 approved drugs to identify the most effective treatment against the bacteria, and the common painkiller ibuprofen has emerged as a particularly potent weapon when used in combination with antibiotics.
Q fever, which can be contracted from cattle, sheep, and goats, has the potential to evolve into a chronic illness, manifesting in symptoms such as severe fatigue, headaches, depression, and psychiatric issues. The disease has been a concern for troops worldwide since the 1950s, and just one inhaled organism is enough to trigger it, leading to approximately 60 reported cases annually in England and Wales.
Breakthrough in Q Fever Treatment
The groundbreaking research at Porton Down reflects the Ministry of Defence’s commitment to addressing health threats for both military personnel and the general population. The scientists, led by Prof. Tim Atkins, known for his work on identifying the Novichok nerve agent, are dedicated to characterizing microorganisms, developing sophisticated detection systems, and creating medical countermeasures.
Q fever falls under the third level of hazards, categorized alongside formidable diseases such as anthrax and the plague. The discovery of ibuprofen’s potential in treating Q fever marks a significant step forward in managing this persistent threat, offering hope for those affected.
